Divi's Laboratories (DIVISLAB)
NSE
Divi's Laboratories (DIVISLAB) NSE/BSE share price, intraday chart and company data on TechGraph.
Current Divi's Laboratories forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—Specialty
About Divi's Laboratories
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly…
Technical analysis
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Buy | Medium-term trend is still up. |
| SMA cross | Buy | The 20-session average is above the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Buy | MACD line is above zero. |
| Stochastic | Neutral | Stochastic is mid-range. |
Company profile
Divi's Laboratories executives and management
Divi's Laboratories financials and ownership
Divi's Laboratories revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 1.08M |
| Shares Outstanding | 270.00M |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Divi's Laboratories revenue by segment
Scroll here to load data.
Divi's Laboratories stock margins
Scroll here to load data.
Divi's Laboratories historical valuation
Scroll here to load data.
Divi's Laboratories annual returns
Scroll here to load data.
Divi's Laboratories financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
News & official updates
Related TechGraph coverage is not available for this instrument yet.
Divi's Laboratories fair value
Scroll here to load data.
Verify with NSE shareholding filings →
Divi's Laboratories options chain
Scroll here to load data.
Divi's Laboratories — frequently asked questions
What is the share price of Divi's Laboratories (DIVISLAB) today?
Divi's Laboratories (DIVISLAB) last traded at ₹9,249.00 (-0.46%) on NSE/BSE, according to TechGraph market data.
Where is Divi's Laboratories listed?
Divi's Laboratories trades as DIVISLAB on NSE.
What is the 52-week range for DIVISLAB?
The 52-week range for DIVISLAB is ₹5,647.50 to ₹9,740.00.
What does Divi's Laboratories do?
Divi's Laboratories is a listed drug manufacturers—specialty company in the healthcare sector, traded on NSE.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.